Allocations
UK private equity fund Elaghmore has acquired English Architectural Glazing Limited (EAG). Founded in 1985, EAG specialises in complex and dynamic building facades and is at the forefront of the envelope cladding sector. Elaghmore has acquired the business from its existing management team who will remain with the Company.
EAG provides envelope cladding packages to an established base of long-standing clients including Stanhope, Kier, BAM and Skanska. EAG operates from three sites in Attleborough (Norfolk), Mildenhall (Suffolk) and Cannock (Staffordshire), employing 125 people. The business is focused on London and the South East and works in a variety of sectors
CSL Capital Management has launched CSL Ventures, a new investment initiative focused on early stage and technology-focused opportunities across the energy services industry.
The new strategy will be part of the firm’s latest fund CSL Energy Opportunities Fund III. The energy industry is entering an era where technological innovation has become essential to facilitate cost reduction, efficiency improvement, and meet new environmental and social goals. In this environment, there is a growing need to provide long-term sustainable capital, operational knowledge and guidance to emerging energy technology companies.
Charlie S Leykum, Founding Partner of CSL Capital, says: “We are launching CSL
Genuine Parts Company is to sell its wholly-owned subsidiary EIS, the Electrical Specialties Group of Motion Industries, to Audax Private Equity (Audax).
GPC intends to use the net cash proceeds from the transaction in accordance with its disciplined capital allocation strategy. The use of these funds may include potential investments for both organic and acquisitive growth, reinvestments in the business, share repurchases and the repayment of debt. The transaction is expected to close by the end of September 2019, subject to the satisfaction of customary closing conditions.
EIS is a well-established and growing North American fabricator, converter and distributor of
Alpine Investors (Alpine), a middle-market private equity firm that focuses on people to build enduring companies, has sold Perennial EdTech (Perennial), its platform of market-leading education software companies, to Frontline Education, a provider of school administration software.
Terms of the private transaction have not been disclosed.
Since Alpine launched the Perennial platform in 2017 shortly after the firm’s acquisition of Escape Technology, which was rolled into Perennial, it has significantly broadened the product portfolio and more than quadrupled revenues over the past two years. Perennial now includes five market-leading software companies in the K-12 education space:
• Escape
Sunstone Management, a diversified capital management and investment firm based in Long Beach, California, has launched a new fund to facilitate the growth of startups participating in the Long Beach Accelerator program.
The fund, designated LBA Sunstone Fund I, will offer investors an opportunity to aid exciting early-stage companies while also generating attractive returns on investment.
The Long Beach Accelerator program, the first of its kind in the City of Long Beach, is a public-private partnership between Sunstone Management, the City of Long Beach and California State University Long Beach. Expected to welcome its first cohort this fall, the accelerator
ClearCourse Partnership (ClearCourse), a group of technology companies providing software, services and digital capabilities to the membership, events & bookings and sports & leisure sectors, has acquired e-clinic, a patient and clinic management software provider.
The deal is ClearCourse’s 13th since its foundation in October 2018 and represents an expansion of Partnership’s product offering into the healthcare industry.
e-clinic was founded in 2002 and continues to operate from its headquarters in Shipley, West Yorkshire, where it employs seven people. Its intuitive proprietary cloud-based software package, ‘e-clinic 2’ is used by clients around the world, from small private medical practices to
Novasec has launched a new investment platform, which connects investors with unique opportunities in the fast-growing renewable energy sector.
Through a careful project selection process, Novasec’s platform combines the renewable energy sector with digital securities, providing investors the potential for lower-risk, competitive returns.
“Novasec is proud to help fund the future of the energy industry, offering accredited investors access to attractive renewables opportunities,” says Michael Tishler, CEO and Co-Founder. “Our team of professionals brings together experience from across the financial services, private equity and renewable energy industries, which has allowed us to build a unique end-to-end platform that will benefit
An affiliate of Saroras Private Capital (Saroras), a private equity investment firm focused on the technology-enabled services industry, has made a majority investment into InCrowd, a specialist in real-time data market insights in the life sciences industry.
The Saroras team has significant experience investing in and building industry-leading companies in the data-driven insights and other growth-oriented industries.
In conjunction with the investment, Daniel S Fitzgerald, has been named chief executive officer & president of InCrowd. Fitzgerald has over 25 years of proven management and operating experience in the insights and data services industry and was most recently a senior executive
Graphite Capital, a UK mid-market private equity specialist, has backed the management buy-out of Hanson Wade, a conference organiser and provider of information services, focused primarily on the pharmaceutical and biotech industries.
Hanson Wade’s management team is led by Tom Richardson, who has overseen a period of rapid expansion since being appointed chief executive in 2015. Between 2016 and 2018, the company’s portfolio of events almost doubled to 108 and its revenues increased by 117 per cent to GBP22.6 million.
Hanson Wade is based in London, but generates the overwhelming majority of its revenues in the United States, where
Equistone Partners Europe (Equistone) is to acquire a majority stake in Omnicare, a pharmaceutical wholesaler operating throughout Germany, that primarily distributes finished medicinal products to compounding pharmacies for the patient-specific production of cancer drugs.
Omnicare is being bought from a consortium of shareholders which will retain a stake in the company. The existing management team, led by Managing Director, Oliver Tamimi, will continue to run the company following the deal. The financial terms of the transaction are undisclosed and the acquisition remains subject to clearance from the relevant competition authorities. The transaction is expected to be complete in Q4 2019.
Events
12 November, 2026 – 8:00 am
12 November, 2026 – 5:00 pm
